LifeMD annual revenue
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
LifeMD Revenue Growth & History (LFMD)
LifeMD reported $194.1M in revenue for fiscal 2025, an increase of 25.34% from the previous fiscal year.
View full LifeMD company overviewLifeMD annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $194.1M | $39.2M | +25.34% |
| 2024 | 2024-12-31 | $154.8M | $2.3M | +1.49% |
| 2023 | 2023-12-31 | $152.5M | $33.5M | +28.15% |
| 2022 | 2022-12-31 | $119.0M | $26.2M | +28.16% |
| 2021 | 2021-12-31 | $92.9M | $55.6M | +149.04% |
| 2020 | 2020-12-31 | $37.3M | $24.8M | +199.10% |
| 2019 | 2019-12-31 | $12.5M | $12.4M | +29227.48% |
| 2018 | 2018-12-31 | $42,515 | $19,315 | +83.25% |
| 2017 | 2017-12-31 | $23,200 | −$5.2M | −99.56% |
| 2016 | 2016-12-31 | $5.2M | $4.0M | +329.79% |
| 2015 | 2015-12-31 | $1.2M | $504,704 | +70.67% |
| 2014 | 2014-12-31 | $714,158 | −$94,205 | −11.65% |
| 2013 | 2013-12-31 | $808,363 | $134,585 | +19.97% |
| 2012 | 2012-12-31 | $673,778 | — | — |
LifeMD quarterly revenue
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q1.24
Q2.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $47.3M | −$1.7M | −3.55% |
| Q1 2026 | 2026-03-31 | $50.2M | −$724,943 | −1.42% |
| Q4 2025 | 2025-12-31 | $34.0M | $27.2M | +403.67% |
| Q3 2025 | 2025-09-30 | $60.2M | $6.9M | +12.95% |
| Q2 2025 | 2025-06-30 | $49.0M | −$1.6M | −3.24% |
| Q1 2025 | 2025-03-31 | $50.9M | $6.7M | +15.28% |
| Q4 2024 | 2024-12-31 | $6.7M | −$38.1M | −84.96% |
| Q2 2024 | 2024-09-30 | $53.3M | $14.7M | +37.96% |
| Q1 2024 · Jun 30 | 2024-06-30 | $50.7M | $14.7M | +40.94% |
| Q1 2024 · Mar 31 | 2024-03-31 | $44.1M | $11.0M | +33.26% |
| Q4 2023 | 2023-12-31 | $44.9M | $16.7M | +59.53% |
| Q3 2023 | 2023-09-30 | $38.6M | $7.2M | +22.93% |
| Q2 2023 | 2023-06-30 | $35.9M | $5.5M | +18.02% |
| Q1 2023 | 2023-03-31 | $33.1M | $4.1M | +14.06% |
| Q4 2022 | 2022-12-31 | $28.1M | $702,832 | +2.56% |
| Q3 2022 | 2022-09-30 | $31.4M | $6.5M | +25.92% |
| Q2 2022 | 2022-06-30 | $30.5M | $8.1M | +36.50% |
| Q1 2022 | 2022-03-31 | $29.0M | $10.8M | +59.59% |
| Q4 2021 | 2021-12-31 | $27.4M | $14.5M | +112.64% |
| Q3 2021 | 2021-09-30 | $24.9M | $13.9M | +126.67% |
| Q2 2021 | 2021-06-30 | $22.3M | $13.2M | +145.48% |
| Q1 2021 | 2021-03-31 | $18.2M | $13.9M | +322.74% |
| Q4 2020 | 2020-12-31 | $12.9M | $8.9M | +226.88% |
| Q3 2020 | 2020-09-30 | $11.0M | $7.9M | +251.99% |
| Q2 2020 | 2020-06-30 | $9.1M | $6.4M | +236.86% |
| Q1 2020 | 2020-03-31 | $4.3M | $1.6M | +59.50% |
| Q4 2019 | 2019-12-31 | $3.9M | $10.0M | +164.69% |
| Q3 2019 | 2019-09-30 | $3.1M | $631,303 | +25.30% |
| Q2 2019 | 2019-06-30 | $2.7M | $660,771 | +32.43% |
| Q1 2019 | 2019-03-31 | $2.7M | $1.1M | +68.01% |
| Q4 2018 | 2018-12-31 | −$6.1M | −$3.2M | −113.44% |
| Q3 2018 | 2018-09-30 | $2.5M | $443,690 | +21.63% |
| Q2 2018 | 2018-06-30 | $2.0M | $1.4M | +208.69% |
| Q1 2018 | 2018-03-31 | $1.6M | $1.4M | +856.82% |
| Q4 2017 | 2017-12-31 | −$2.9M | −$3.8M | −389.74% |
| Q3 2017 | 2017-09-30 | $2.1M | $667,305 | +48.20% |
| Q2 2017 | 2017-06-30 | $660,087 | −$567,160 | −46.21% |
| Q1 2017 | 2017-03-31 | $167,899 | −$1.5M | −89.77% |
| Q4 2016 | 2016-12-31 | $985,900 | $612,551 | +164.07% |
| Q3 2016 | 2016-09-30 | $1.4M | $1.1M | +394.65% |
| Q2 2016 | 2016-06-30 | $1.2M | $949,894 | +342.49% |
| Q1 2016 | 2016-03-31 | $1.6M | $1.4M | +469.25% |
| Q4 2015 | 2015-12-31 | $373,349 | $213,700 | +133.86% |
| Q3 2015 | 2015-09-30 | $279,883 | $114,414 | +69.15% |
| Q2 2015 | 2015-06-30 | $277,353 | $80,742 | +41.07% |
| Q1 2015 | 2015-03-31 | $288,277 | $95,848 | +49.81% |
| Q4 2014 | 2014-12-31 | $159,649 | −$877 | −0.55% |
| Q3 2014 | 2014-09-30 | $165,469 | $70,793 | +74.77% |
| Q2 2014 | 2014-06-30 | $196,611 | −$126,292 | −39.11% |
| Q1 2014 | 2014-03-31 | $192,429 | −$37,829 | −16.43% |
| Q4 2013 | 2013-12-31 | $160,526 | $44,965 | +38.91% |
| Q3 2013 | 2013-09-30 | $94,676 | −$57,439 | −37.76% |
| Q2 2013 | 2013-06-30 | $322,903 | $95,337 | +41.89% |
| Q1 2013 | 2013-03-31 | $230,258 | $51,722 | +28.97% |
| Q4 2012 | 2012-12-31 | $115,561 | — | — |
| Q3 2012 | 2012-09-30 | $152,115 | — | — |
| Q2 2012 | 2012-06-30 | $227,566 | — | — |
| Q1 2012 | 2012-03-31 | $178,536 | — | — |
LifeMD revenue growth trends
Over the last five reported fiscal years, revenue grew from $37.3M to $194.1M, a compound annual growth rate of 39.08%. LifeMD's latest reported quarter, Q2 2026, generated $47.3M in revenue, a decrease of 3.55% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review LifeMD source filings ↗